With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ...

Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.

A first-of-its-kind treatment center aimed at helping those living with or at risk of HIV is now open in Minneapolis.

A man who has lived with HIV for 12 years is part of a campaign to raise awareness of the stigma associated with the ...

In two mid-Michigan school districts where the HIV education curriculum was discovered to be out of date a year ago by 6 News ...

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...

Genetic Immunity, a leader in plasmid DNA-based immunotherapies, and VectorBuilder, a global specialist in gene delivery solutions, announced a strategic partnership to advance Genetic Immunity's ...

Ending AIDS as a public health threat by 2030 is a real possibility, tantalizingly close. But the job is not yet done.

Argentines living with HIV/AIDS and medics say spending cuts under libertarian President Javier Milei are hurting treatment ...

A collaborative effort by residents and moves to uphold human rights are key to eliminating HIV/Aids as a public health issue ...

HIV/AIDS awareness is vital for creating a healthier, stigma-free world. World AIDS Day serves as a global platform to educate people about HIV, its prevention, and the importance of compassionate ...

The National AIDS Memorial has honored Dan Bernal, UCSF vice chancellor for community and government relations, for his ...